<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2007-09-24 19:00:00Biology Factor H Hemolytic-uremic syndrome Complement factor I CFHR1 CFHR3 CFHR4 CD46 Complement component 3 Complement system Anatomy Medicine |
Add to Reading List |
Microsoft PowerPoint - fig1 | 5 Life Science PF Activity Report 2011 #29 Structural Basis of Measles Virus Entry and Effective Measles VaccineDocID: 17Bb9 - View Document |
| Microsoft PowerPoint - fig1DocID: Qr71 - View Document |
| Phase I trial of systemic administration of Edmonston strain of measles virus, genetically engineered to express NIS, with or without cyclophosphamide, in patients with recurrent or refractrory multiple myeloma Angela DiDocID: FyCc - View Document |
| Shigetaka KATOW 1978DocID: 3b5h - View Document |